Prostate Cancer - Results from #24620

Analysis of late toxicity associated with external beam radiation therapy for prostate cancer with uniform setting of classical 4-field 70 Gy in 35 fractions: A survey study by the Osaka Urological Tumor Radiotherapy Study Group - Abstract October 11, 2012

Systematic evaluation of three different commercial software solutions for automatic segmentation for adaptive therapy in head-and-neck, prostate and pleural cancer - Abstract October 11, 2012

Prostate cancer incidence and newly diagnosed patient profile in Spain in 2010 - Abstract October 11, 2012

High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives - Abstract October 11, 2012

Loss of masculine identity, marital affection, and sexual bother in men with localized prostate cancer - Abstract October 11, 2012

European Association of Urology Guidelines on Laser Technologies - Abstract October 11, 2012

Using age-referenced prostate-specific antigen percentile to predict survival outcomes in screened Taiwanese men - Abstract October 10, 2012

Measures of combined antioxidant and pro-oxidant exposures and risk of overall and advanced stage prostate cancer - Abstract October 10, 2012

Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer - Abstract October 10, 2012

Development of a new optical device and its feasibility in prostate cancer detection - Abstract October 10, 2012

A gene expression signature predicting high grade prostate cancer response to oxaliplatin - Abstract October 10, 2012

Low-dose rate brachytherapy of the prostate in elderly patients - Abstract October 10, 2012

Dynamic contrast-enhanced MR evaluation of prostate cancer before and after endorectal high-intensity focused ultrasound - Abstract October 10, 2012

Adjuvant and salvage radiotherapy after prostatectomy: Outcome analysis of 307 patients with prostate cancer - Abstract October 10, 2012

Multitargeted tyrosine kinase inhibition produces discordant changes between 99mTc-MDP bone scans and other disease biomarkers: Analysis of a phase II study of sunitinib for metastatic castration-resistant prostate cancer - Abstract October 9, 2012

The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiation - Abstract October 9, 2012

A comparison of preplan MRI and preplan CT-based prostate volume with intraoperative ultrasound-based prostate volume in real-time permanent brachytherapy - Abstract October 9, 2012

Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programme - Abstract October 9, 2012

Anogenital distance and the risk of prostate cancer - Abstract October 9, 2012

Prevalence and predictors of selenium and vitamin E supplementation in a urology population - Abstract October 9, 2012

Page 1232 of 1435